How Sonovein built a brand as precise as its robotics, and made a new category feel inevitable.

Sonovein is a robotic HIFU platform from Theraclion. It treats varicose veins with no incisions, no needles, no anesthesia. The technology was ready for global growth and US market entry. The brand was not.

Two audiences had to be convinced at once. Vascular specialists needed clinical proof and scientific precision. Patients needed a plain account of what incision-free treatment actually means for them. Most medtech brands pick one of those audiences and lose the other.

1. Claim the category

‍We repositioned Sonovein around three things a first mover can own: category leadership, patient outcomes, and scientific credibility. The identity follows the same logic. A restrained palette, clinical typography, and a mark that reads as precise rather than promotional.

2. Make the technology legible

‍We built a technical illustration and animation system that breaks the device and the treatment into ownable visual moments. Then we shot photography and film that place the technology in real clinical settings, with real people. The science stays intact. The audience stops needing a translator.

3. Build one platform for two audiences

‍The website splits the message without splitting the brand. Clinicians get the mechanism, the data, and the procedural detail. Patients get a clear account of what treatment involves and what recovery looks like. Both routes run on the same identity, the same illustration system, and the same voice.

Sonovein had the technology to redefine vein care. It now has the strategy, identity, website, and content system to make that future feel inevitable. The story carries into every new market without being rebuilt each time.